TZ Ref No.: TZ-26-1417339
GlycoIMPACT - Glycoengineering for Immune Modulation in Precision Anti-Cancer Therapies
Doc ref no.
1012•••
Sector
Services
Contract Date
30 Mar 2026
Contract Value
EUR ••••••
Contract Intelligence
AI opportunity notes and scope analysis for this contract award
Opportunity Notes
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Official Award Result
Status: Contract Awarded
Award Date: 30 Mar 2026
Awarded Contractor / Winner
UNIV•••
Awarded Contract Value:
EUR 230,184.72
Execution Period:
01 Jan 2027 → 31 Dec 2028
(730 days)
Contract Description
Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers, with a five-year survival rate below 10% due to late diagnosis, immune exclusion, and resistance to existing immunotherapies. GlycoIMPACT tackles these challenges by developing an innovative glycan-based...